Parallel trade in drugs ‘saves millions’

A study conducted by the University of Southern Denmark on behalf of the European Association of Euro-Pharmaceutical Companies concludes that intermediaries who buy medicines at low cost in some European countries for resale at higher prices elsewhere save patients and health insurers hundreds of millions of euros a year.

European Association of Euro-Pharmaceutical Companies: Press Release: New report proves savings from parallel trade in drugs - and says they could be larger, 20.6.06 http://www.eaepc.org/admin/files/eaepc_press_release_on_new_economic_study.doc

University of Southern Denmark: Report: The economic impact of parallel import of pharmaceuticals, June 2006 http://www.cast.sdu.dk/pdf/Parallel_import_rapport_13_06_1430_opdateret_final.pdf

---